Hyman Schipper

Dr. Hyman Schipper

McGill University, Montréal, Quebec, Canada
+1
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2009 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
HSHyman Schipper
Hyman Schipper
WSWei Song
Wei Song
HZHillel Zukor
Hillel Zukor
JHJacob R. Hascalovici
Jacob R. Hascalovici
DZDavid Zeligman
David Zeligman

15 July 2002
Verified
Journal Article
Closed access
WMWilson H Miller
Wilson H Miller
HSHyman Schipper
Hyman Schipper
JLJanet S Lee
Janet S Lee
JSJack Singer
Jack Singer
SWSamuel Waxman
Samuel Waxman

1 December 2004 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
HSHyman Schipper
Hyman Schipper

1 May 2009 in Current Genomics
Verified
Journal Article
Open access
PDF file
OMOlivier C. Maes
Olivier C. Maes
HCHoward M. Chertkow
Howard M. Chertkow
EWEugenia Wang
Eugenia Wang
HSHyman Schipper
Hyman Schipper
Understanding complex diseases such as sporadic Alzheimer disease (AD) has been a major challenge. Unlike the familial forms of AD, the genetic and environmental risks factors identified for sporadic AD are extensive. MicroRNAs are one of the major noncoding RNAs that function as negative regulators to silence or suppress gene expression via translational inhibition or message degradation. Their discovery has evoked great excitement in biomedical research for their promise as potential disease biomarkers and therapeutic targets. Key microRNAs have been identified as essential for a variety of cellular events including cell lineage determination, proliferation, apoptosis, DNA repair, and cytoskeletal organization; most, if not all, acting to fine-tune gene expression at the post-transcriptional level in a host of cellular signaling networks. Dysfunctional microRNA-mediated regulation has been implicated in the pathogenesis of many disease states. Here, the current understanding of the role of miRNAs in the central nervous system is reviewed with emphasis on their impact on the etiopathogenesis of sporadic AD.

1 January 2019 in Progress in Neurobiology
Verified
Journal Article
Closed access
HSHyman Schipper
Hyman Schipper
WSWei Song
Wei Song
ATAyda Tavitian
Ayda Tavitian
MCMarisa Cressatti
Marisa Cressatti

10 May 2007 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
JVJacob Vaya
Jacob Vaya
HSHyman Schipper
Hyman Schipper